v3.22.2.2
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2022 and 2021, were as follows (in thousands):

    

Three Months Ended

    

Nine Months Ended

    

September 30, 

    

September 30, 

    

2022

    

2021

    

2022

    

2021

Net sales

 

  

 

  

 

  

 

  

Cardiovascular

$

278,949

$

259,704

$

832,555

$

773,002

Endoscopy

 

8,226

 

7,317

 

25,011

 

23,257

Total net sales

 

287,175

 

267,021

 

857,566

 

796,259

Income from operations

 

  

 

  

 

  

 

  

Cardiovascular

 

17,435

 

14,411

 

51,836

 

33,389

Endoscopy

 

1,222

 

1,520

 

5,310

 

5,631

Total income from operations

 

18,657

 

15,931

 

57,146

 

39,020

Total other expense — net

 

(1,055)

 

(1,754)

 

(4,672)

 

(5,284)

Income tax expense

 

2,330

 

2,210

 

11,359

 

5,895

Net income

$

15,272

$

11,967

$

41,115

$

27,841